# K073471: Vantagecath Intravascular Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Advantage Medical Device
- Decided: Apr 30, 2008 after 141 days
- Product code: FOZ (Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K971339 (1997). 2 ancestors in all.
No later device cites it as a predicate yet.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K032843: Nexiva Closed IV Catheter System, Becton Dickinson Infusion Therapy Systems, Inc. (2004) Summary page 1.
- K971339: Insyte, Insyte-W, Insyte Autoguard Catheters, Becton Dickinson Vascular Access, Inc. (1997) Summary page 1.

## Indications for use
The VantageCath TM is a short-term intravascular catheter which allows health care practitioner to sample blood and administer fluids or medication intravenously. These catheters may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness for the solution being infused, and the duration of therapy. The VantageCath TM catheter provides a shielding mechanism intended to reduce the incidence of accidental needle sticks. When the needle retracts into the needle-shielding barrel, the catheter hub and needle assembly components are automatically separated.

Source page: https://510kreport.com/device/K073471
Methodology: https://510kreport.com/methodology